Role of Hypoxia-Inducible Factors in Respiratory Syncytial Virus Infection-Associated Lung Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dorothea R Morris und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hypoxia-Inducible Factor 1, alpha Subunit, Basic Helix-Loop-Helix Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH Clinical and Translational Science Award NRSA (TL1) Training Core, NIH HHS.
Abstract (Originalsprache)
Hypoxia-inducible factors (HIFs) are transcription factors that enable cells to adapt to low-oxygen environments. Viruses can exploit this pathway to enhance infection, making HIF modulation a potential antiviral strategy. In previous in vitro studies, we found that respiratory syncytial virus (RSV) stabilizes HIFs under normoxic conditions with inhibition of HIF-1α reducing replication. Despite several HIF-modulating compounds being tested or approved in other non-infectious models, little is known about their efficacy against respiratory viruses in relevant animal models. This study aimed to characterize the disease-modulating properties and antiviral potential of HIF-1α (PX478) and HIF-2α PT2385 inhibitors in RSV-infected BALB/c mice. We found that the inhibition of HIF-1α worsened clinical disease parameters while simultaneously improving airway function. Blocking HIF-1α also significantly reduced peak RSV replication in the lung. In contrast, the inhibition of HIF-2α was associated with improved clinical parameters, no changes in airway function, and reduced viral replication following RSV infection. The analysis of lung cells found significant modification in the T-cell compartment that correlated with changes in lung pathology and viral titers for each HIF inhibitor. This study underscores the differential roles of HIF proteins in RSV infection and highlights the need for further characterization of compounds currently in use or under therapeutic consideration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
- School of Population & Public Health, The University of Texas Medical Branch, Galveston, TX 77555, USA.
- Department of Pediatrics, The University of Texas Medical Branch, Galveston, TX 77555, USA.
- School of Veterinary Medicine & Biomedical Science, Texas A&M University, College Station, TX 77843, USA.
ORCID-Profile: Dorothea R Morris, Yue Qu, Aline Haas de Mello
Förderung
- NIAID NIH HHS
- NIH Clinical and Translational Science Award NRSA (TL1) Training Core
- NIH HHS
- NCATS NIH HHS
- McLaughlin Endowment Predoctoral Fellowship
- Institute for Human Infections and Immunity (IHII)
Zitieren
APA
Morris, D. R., Qu, Y., Haas de Mello, A., Jones-Hall, Y. L., Liu, T., Weglarz, M., Ivanciuc, T., Garofalo, R. P., & Casola, A. (2025). Role of Hypoxia-Inducible Factors in Respiratory Syncytial Virus Infection-Associated Lung Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073182
Vancouver
Morris DR, Qu Y, Haas de Mello A, Jones-Hall YL, Liu T, Weglarz M, et al. Role of Hypoxia-Inducible Factors in Respiratory Syncytial Virus Infection-Associated Lung Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073182
BibTeX
@article{Morris2025,
author = {Morris, Dorothea R and Qu, Yue and Haas de Mello, Aline and Jones-Hall, Yava L and Liu, Tianshuang and Weglarz, Meredith and Ivanciuc, Teodora and Garofalo, Roberto P and Casola, Antonella},
title = {Role of Hypoxia-Inducible Factors in Respiratory Syncytial Virus Infection-Associated Lung Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073182}
}
EUVIMED